Subcutaneous amivantamab delivered every 4 weeks (Q4W) provides similar efficacy as the intravenous regimen every 2 weeks but provides the benefit of...

A clinical trial of patients with relapsed or refractory (R/R) large B-cell lymphoma (LBCL) who were treated with axicabtagene ciloleucel (axi-cel) in...

Content above is prompted by the following: Health care providers must adapt treatment recommendations when patients face insurance coverage limitatio...

Content above is prompted by the following: Health care providers require specialized training resources to effectively recognize and manage AD across...

Budget cuts to US foreign aid threaten to upend essential aid programs—like tuberculosis (TB) care programs and other critical health services—potenti...

Am J Manag Care. 2025;31(Spec. No. 10):SP728-SP732. https://doi.org/10.37765/ajmc.2025.89800 _____ Experts from across Providence Health & Services ga...

August was another busy month for the FDA, which approved several groundbreaking therapies, including first-in-class and first-in-disease treatments a...

News Article Author(s): Fact checked by: Coverage of our peer-reviewed research and news reporting in the health care and mainstream press. An article...

Achieving alignment between health care providers and payers can be challenging, but consistent collaboration and shared accountability can help keep...

Metabolic dysfunction–associated steatohepatitis (MASH) is on track to drive major clinical and economic consequences worldwide, according to new proj...